Jubilant Life Sciences Shares
- All
- News
- Videos
-
Jubilant Life To Buy Triad Isotopes' Radio-Pharmacy Business, Shares Gain
Jubilant Life Sciences said Triad operates the second largest radio-pharmacy network in the US with more than 50 pharmacies.
-
Nearly 200 Stocks Hit 52-Week High On BSE
Among major gainers were IL&FS Transportation Networks, IOC, Jubilant Life Sciences, MMTC and MOIL, taking the total number of companies to have touched their one year peak to 192.
-
Jubilant Life Sciences Unit Signs US Deal, Shares Surge Over 10%
At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions.
-
Jubilant Life Sciences Posts Nearly 15% Rise In Q2 Profit
Jubilant Life Sciences said its international revenues were at Rs 984 crore, contributing 69 per cent to the revenues for the quarter.
-
Jubilant Life Shares Jump 10% As Arm Gets USFDA Nod For Drug
Shares of Jubilant Life Sciences on Monday surged 10 per cent after the company's wholly-owned subsidiary received approval from the US health regulator for a new drug in the US market.
-
Jubilant Pharma Raises $300 Million Via Bonds
Drug firm Jubilant Life Sciences today said its subsidiary Jubilant Pharma has raised $300 million (approx Rs 1,998 crore) through issuance of five-year bonds to mainly retire debts.
-
Jubilant Life Jumps 8% On USFDA Nod For Hypertension Tablets
Jubilant Life Sciences stock surged nearly 8 per cent after it received final approval from the US health regulator to sell tablets used in the treatment of hypertension in the American market.
-
Jubilant Life Sciences Surges Over 50% In 7 Days. Read Why
Shares of Jubilant Life Sciences shares surged 15 per cent today to a fresh 52-week high of Rs 506, extending their strong run since the pharma company announced its June quarter earnings last week.
-
Jubilant Life Sciences Posts 22% Rise In Q1 Profit
Jubilant Life Sciences on Tuesday posted a 22.48 per cent rise in consolidated net profit at Rs 161.60 crore for the first quarter that ended on June 30, on robust sales in the pharmaceuticals segment.
-
Jubilant Life Sciences Shares Jump On Approval For Epilepsy Injection
With this approval, Jubilant Life Sciences' total Abbreviated New Drug Application (ANDA) approvals rose to 517 in various regions globally, the company said.
-
Jubilant Life Sciences Gets Shareholders' Nod To Raise Up To Rs 1,340 Crore
Drug firm Jubilant Life Sciences has received approval of its shareholders to raise up to $200 million (around Rs 1,340 crore) to fund expansion including acquisition and additional working capital needs.
-
Jubilant Life, Australian Firm Terminate Pact For Imaging Agent Rights
Jubilant Life Sciences on Wednesday said its wholly-owned subsidiary and Australia-based Cyclopharm have mutually called off their previously announced term sheet for exclusive commercial rights of Technegas in the US market.
-
Deutsche Securities Sells Rs 122-Crore Stake in Jubilant Life
Deutsche Securities Mauritius on Tuesday offloaded a 1.95 per cent stake in drug firm Jubilant Life Sciences for a little over Rs 122 crore through an open market transaction.
-
Foreign Investors Can Pick up to 45% in Jubilant Life: RBI
The Reserve Bank of India has allowed foreign investors to pick up to 45 per cent in Jubilant Life Sciences under the portfolio investment scheme (PIS).
-
Jubilant Life Zooms 10% on USFDA Nod for Anti-Depressant Drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its fresh 52-week high on Tuesday, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
-
Jubilant Life To Buy Triad Isotopes' Radio-Pharmacy Business, Shares Gain
Jubilant Life Sciences said Triad operates the second largest radio-pharmacy network in the US with more than 50 pharmacies.
-
Nearly 200 Stocks Hit 52-Week High On BSE
Among major gainers were IL&FS Transportation Networks, IOC, Jubilant Life Sciences, MMTC and MOIL, taking the total number of companies to have touched their one year peak to 192.
-
Jubilant Life Sciences Unit Signs US Deal, Shares Surge Over 10%
At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions.
-
Jubilant Life Sciences Posts Nearly 15% Rise In Q2 Profit
Jubilant Life Sciences said its international revenues were at Rs 984 crore, contributing 69 per cent to the revenues for the quarter.
-
Jubilant Life Shares Jump 10% As Arm Gets USFDA Nod For Drug
Shares of Jubilant Life Sciences on Monday surged 10 per cent after the company's wholly-owned subsidiary received approval from the US health regulator for a new drug in the US market.
-
Jubilant Pharma Raises $300 Million Via Bonds
Drug firm Jubilant Life Sciences today said its subsidiary Jubilant Pharma has raised $300 million (approx Rs 1,998 crore) through issuance of five-year bonds to mainly retire debts.
-
Jubilant Life Jumps 8% On USFDA Nod For Hypertension Tablets
Jubilant Life Sciences stock surged nearly 8 per cent after it received final approval from the US health regulator to sell tablets used in the treatment of hypertension in the American market.
-
Jubilant Life Sciences Surges Over 50% In 7 Days. Read Why
Shares of Jubilant Life Sciences shares surged 15 per cent today to a fresh 52-week high of Rs 506, extending their strong run since the pharma company announced its June quarter earnings last week.
-
Jubilant Life Sciences Posts 22% Rise In Q1 Profit
Jubilant Life Sciences on Tuesday posted a 22.48 per cent rise in consolidated net profit at Rs 161.60 crore for the first quarter that ended on June 30, on robust sales in the pharmaceuticals segment.
-
Jubilant Life Sciences Shares Jump On Approval For Epilepsy Injection
With this approval, Jubilant Life Sciences' total Abbreviated New Drug Application (ANDA) approvals rose to 517 in various regions globally, the company said.
-
Jubilant Life Sciences Gets Shareholders' Nod To Raise Up To Rs 1,340 Crore
Drug firm Jubilant Life Sciences has received approval of its shareholders to raise up to $200 million (around Rs 1,340 crore) to fund expansion including acquisition and additional working capital needs.
-
Jubilant Life, Australian Firm Terminate Pact For Imaging Agent Rights
Jubilant Life Sciences on Wednesday said its wholly-owned subsidiary and Australia-based Cyclopharm have mutually called off their previously announced term sheet for exclusive commercial rights of Technegas in the US market.
-
Deutsche Securities Sells Rs 122-Crore Stake in Jubilant Life
Deutsche Securities Mauritius on Tuesday offloaded a 1.95 per cent stake in drug firm Jubilant Life Sciences for a little over Rs 122 crore through an open market transaction.
-
Foreign Investors Can Pick up to 45% in Jubilant Life: RBI
The Reserve Bank of India has allowed foreign investors to pick up to 45 per cent in Jubilant Life Sciences under the portfolio investment scheme (PIS).
-
Jubilant Life Zooms 10% on USFDA Nod for Anti-Depressant Drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its fresh 52-week high on Tuesday, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
